What Is the GAP Index for Interstitial Lung Disease?

The GAP index is a risk-assessment tool used by doctors to estimate population-level mortality risk for people with Interstitial Lung Disease (ILD)—most specifically, it was originally designed for Idiopathic Pulmonary Fibrosis (IPF). GAP stands for Gender (biological sex), Age, and Physiology (your lung function tests). If you have searched for your GAP score online and are panicked by the statistics, it is crucial to understand this: a GAP score is not a personal expiration date. The original statistics were built before modern treatments existed, and the model describes group averages, not your individual path.

What Does the GAP Index Measure?

The GAP index calculates a score based on four variables. Because different studies use slightly different scoring methods (such as adding points if a test cannot be performed), scores typically range from 0 to 8 ^[1][2]. The components include:

• Gender/Sex: The original statistical model assigns 1 point for male sex, as historical data showed men progressed slightly faster in IPF ^[1].
• Age: Older age adds up to 2 points ^[1].
• Physiology (FVC): Forced Vital Capacity measures how much air you can forcefully exhale ^[1]. The calculator uses your “percent predicted” (your results compared to healthy peers of the same age, sex, and height). Lower percentages add points.
• Physiology (DLCO): Diffusing Capacity of the Lungs for Carbon Monoxide is an estimate of how well gases move from the air sacs into the bloodstream ^[1]. Lower percentages, or being entirely unable to perform this test, add the most points.

Doctors add these points to place patients into Stages (I, II, or III) ^[2]. While a higher score indicates a statistically higher mortality risk for a population over a specific time period, it does not measure how fast your individual FVC is currently declining, nor does it predict exactly what will happen to you ^[1]. Additionally, while originally built for IPF, the GAP index is sometimes applied to other types of ILD (like autoimmune-related ILD), where its accuracy can vary significantly ^[3].

Why Historical Statistics Don’t Tell the Whole Story

The most significant limitation of online GAP mortality statistics is that the original model was developed using historical data from patients who were not taking modern treatments ^[4].

Today, antifibrotic medications (like nintedanib and pirfenidone) are available to help slow down lung scarring and the decline of FVC. Research directly comparing contemporary patients to the original GAP estimates shows that the original index often overpredicts absolute mortality in the modern treatment era ^[4][5]. While antifibrotics do not reverse established fibrosis and are not a cure, observational studies associate these treatments with slower functional decline and, in some groups, lower early mortality than the historical models predicted ^[6][7][8].

What the GAP Index Leaves Out

Because the GAP index is a one-time mathematical snapshot, it ignores several crucial factors about your actual health ^[1]:

• How you feel and function: It ignores exercise capacity (such as how far you can walk in six minutes) and whether your oxygen drops during exertion, which are highly important indicators of how you are doing ^[9][10].
• Your disease over time: A single score doesn’t show whether your lung function is dropping rapidly or staying stable for years ^[5].
• CT scan details: It does not account for the specific patterns or extent of scarring visible on your high-resolution CT scans ^[11].
• Supportive care: It does not factor in pulmonary rehabilitation or supplemental oxygen. While these supportive measures do not reverse lung scarring, they can significantly improve your quality of life, breathlessness, and exercise tolerance. (Importantly, if your disease does progress, it is due to the biological nature of the condition, never a failure of your physical conditioning or willpower.)

Your GAP score is just a baseline for a broader conversation with your care team. If you experience sudden or rapidly worsening breathlessness, new chest pain, or concerningly low oxygen readings, do not wait for your next routine lung function test to update a score—seek urgent medical evaluation immediately.